CDKL5 deficiency disorder (CDD) is a rare and severe developmental and epileptic encephalopathy (DEE), affecting around 1 in 40,000 to 60,000 live births. Onset of the disease typically begins in infancy, usually during the first three…
For patients with Hidradenitis Suppurativa (HS), the journey to accurate diagnosis, effective treatment and management, optimal wound care and improved quality of life is often met with lengthy delays. Diagnoses can be fraught with…
Prolonged seizures (PS) present a significant and often underrecognized challenge for people living with epilepsy and their caregivers. Not only do these episodes disrupt daily life and cause seizure worry, but they also carry risks of…
FASTRAX is a global digital initiative led by UCB to address one of rheumatology’s most persistent challenges: the delayed diagnosis of axial spondyloarthritis (axSpA). By creating integrated, country-specific solutions in partnership with…
Article co-authored by Marc De Backer & Natasha Monin, Medical Communications, UCBAt UCB, we are committed to improving the lives of people living with rare diseases such as myasthenia gravis (MG). In our ongoing effort to enhance care in…
Fragility fractures, a clinical signal of underlying osteoporosis, affect millions of women over the age of 50 worldwide. They reduce independence, place a heavy burden on healthcare systems and increase the patient’s risk of another…
As we approach the American College of Rheumatology (ACR) Convergence 2025, Jeff Stark, MD, US Head of Medical Immunology at UCB, and John Ioannou, Global Medical Head, Immunology at UCB, bring together their unique perspectives on the…
A congress of collaboration and progressToday the dermatology community gathers in Paris for the start of the European Academy of Dermatology and Venereology (EADV) 2025 Congress. It is always a special moment in the calendar to hear from…
September brings two important milestones for the Thymidine Kinase 2 Deficiency (TK2d) and mitochondrial disease community – TK2d Tuesday and World Mitochondrial Disease Awareness Week. This is a time when the TK2d and broader…
Developmental and Epileptic Encephalopathies (DEEs) are rare, severe and lifelong epileptic syndromes that not only cause seizures, but also cognitive and motor challenges, and behavioural issues, as well as gastrointestinal,…
As we pass the midpoint of 2025, I am pleased to share that UCB continues to advance with strength and clarity of purpose. In the first half of the year, our revenues increased to €3.49 billion, and our five growth medicines generated more…
UCB is committed to understanding and addressing the unmet needs of patients living with thymidine kinase 2 deficiency (TK2d), an ultra-rare, life-threatening mitochondrial disease with a high mortality rate. According to a meta-analysis…
Digital health at a turning point: from innovation to impact This year’s HLTH theme “Let’s Grow” reflected the importance of delivering impact and accelerating time to value. Overall, trust in and opportunity of AI is high, and…
Empowering Patients to Lead the ChargePeople living with myasthenia gravis (MG) live and breathe the complexities of their condition every day. For this reason, at UCB, we believe that the patient voice is as important as any other…
It’s 8:45 a.m. on Monday morning. By now Gretchen has usually dropped her son Peter*, off at school with his one-on-one helper, and is on her way to work, but on Friday night, Peter had a seizure which was worse than what he normally…
At UCB, we are focused on one thing: delivering value for people living with severe diseases. As more of our innovative medicines reach patients, we are preparing for what comes next — ensuring we can meet growing demand with the…
Imagine a world where the tediousness of traditional clinical trials fades into history. No more regimented site visits, excessive travel, or endless paperwork. Instead, researchers collect your health data seamlessly as you go about your…
June marks Myasthenia Gravis (MG) Awareness Month, a dedicated time for raising awareness about this rare, chronic, autoimmune, neuromuscular condition. During this month, organizations and individuals unite to educate the public, promote…
EULAR 2025 stands as a cornerstone of the rheumatology calendar – a unifying platform where people living with rheumatic diseases, healthcare professionals, and industry partners come together to share, learn, and advance care. It is here…
At RheumaPreg 2025, global experts gathered to explore one of the most complex and critical challenges in rheumatology: how best to support women of childbearing age (WoCBA) living with chronic inflammatory diseases. The congress…
Innovation often begins with collaboration. When two industry leaders join forces, the benefits ripple far beyond their respective organizations. That's precisely what's happening with UCB and Domino Data Lab, a leading data science…
At UCB we have an unwavering focus on patients – every decision, every innovation and every step forward is guided by the ambition to elevate the lives of people living with severe diseases through our medicines. To advance our innovation…
Axial spondyloarthritis (axSpA) is a chronic, immune-mediated inflammatory disease that primarily affects the spine and sacroiliac joints. Symptoms can start in early adulthood and worsen over time. In some cases non-radiographic-axSpA,…
This Saturday, 3 May, people around the world will come together to recognize World AS Day and raise awareness of axial spondyloarthritis (axSpA). It will be an important opportunity to shine a light on the experiences of those living with…
In an exciting move to make patient support more accessible, UCB has partnered with smartpatient, creators of the globally popular MyTherapy mobile health app, to offer a tailored digital health companion for people living with psoriasis.…
In osteoporosis research and clinical practice, the value of real-world evidence (RWE) is increasingly acknowledged; but much of its potential remains untapped. By analyzing real-world treatment patterns, RWE provides deeper insights into…
World Parkinson’s Day is an important moment to reflect on the progress made in improving the lives of people living with Parkinson’s and to highlight ongoing challenges. The PECPR Initiative: A Model for Patient Engagement One of the key…
Living with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) presents unique challenges that can profoundly affect daily life. Approximately, 1.6-4.8 per million people annually are diagnosed with this rare…
At the AD/PD Congress, one of the leading global events for advancing science in Alzheimer’s and Parkinson’s diseases, we are reaffirming our commitment to tackling the challenges of these devastating neurodegenerative diseases. The…
As we prepare for the American Academy of Neurology (AAN) congress, we're excited to showcase UCB's dedication to transforming care for individuals living with neurological conditions. The AAN annual meeting isn't just an event; it's a…